1. Introduction {#sec0005}
===============

The new emergent coronavirus, severe acute respiratory coronavirus 2 (SARS-CoV-2), broke out in Wuhan, China \[[@bib0005]\]. The virus immediately spread worldwide, causing many Covid-19 cases and deaths. SARS-CoV-2 resides in the upper respiratory tract and spreads via droplets from coughing or sneezing. The World Health Organization recommends washing hands with soap, maintaining social distancing, and avoiding crowded places to prevent the spread of viral infections \[[@bib0010]\]. In addition to these preventive measures, most countries recommend travel restrictions and curfews.

Influenza viruses, rhinoviruses, adenoviruses, coronaviruses (229E, OC43, NL63 and HKU1) and the human metapneumovirus cause common cold-like symptoms \[[@bib0015]\]. Of these viruses, influenza viruses are an annual epidemic in the winter. Owing to the development of treatments and vaccines, the mortality rate from influenza viruses is low.

In December 2019, the SARS-CoV-2 outbreak coincided with the influenza viral epidemic. Seasonal influenza activity in Japan was lower in 2020 than in previous years \[[@bib0020]\]. However, whether SARS-CoV-2 is more infectious than other viruses remains unknown. Here, we performed genetic analyses to determine which viruses were spreading in the Japanese population. This epidemiologic study shows the infectability of each virus after implementing social preventive measures against SARS-CoV-2.

2. Materials and methods {#sec0010}
========================

2.1. Patients and samples {#sec0015}
-------------------------

We studied 191 patients exhibiting cold-like symptoms from 10 March 2020 to 7 May 2020 in our district 100--150 km west of Tokyo, Japan. Nasopharyngeal samples were collected from all patients using cotton swabs and universal transport media (Copan, Murrieta, CA, USA). The Institutional Review Board at Yamanashi Central Hospital approved this study and the use of an opt-out consent method (G-2019-30). The requirement for written informed consent was waived. Participation in the study by patients was optional.

2.2. FilmArray Respiratory Panel {#sec0020}
--------------------------------

To analyze the viral species related to patients' respiratory diseases, we performed multiplex PCR targeting 17 viruses and three bacterial species using the FilmArray Respiratory Panel (bioMérieux, Marcy-l\'Etoile, France) per the manufacturer's instructions. Briefly, buffer and 300 μl from the nasopharyngeal swab were injected into the FilmArray pouch. The reaction proceeded automatically on the FilmArray Torch system. The limit of detection was listed as previously reported ([Table 1](#tbl0005){ref-type="table"} ) \[[@bib0025]\].Table 1The list of limit of detection of FilmArray Respiratory Panel.Table 1Viruses and bacteriaStandard strainsLimit of detection (TCID~50~/mL)AdenovirusAdVC1100AdVC2100AdVE4100　AdVC6100Coronavirus 229EATCC VR-7404Coronavirus HKU1Clinical Specimen1.9 × 10^6^ RNA copies/mLCoronavirus NL63NR-4705Coronavirus OC43ATCC VR-759600Human rhinovirus/ EnterovirusHRV Type 1A1　Echovirus 630,000Human metapneumovirushMPV-16, IA10-2003 (Type A1)2Human rhinovirusType 1A1Influenza A H1 (Influenza A H1N1)A/Brisbane/59/07200　A/New Caledonia/20/992000Influenza A H1-2009 (Influenza A H1N1-2009)A/SwineNY/03/2009100Influenza A H3 (Influenza A H3N2)A/Wisconsin/67/20055　A/Port Chalmers/1/7350Influenza BB/FL/04/0660　B/Taiwan/2/6260Parainfluenza virus 1 Type 1Type 1500Parainfluenza virus 2 Type 2Type 210Parainfluenza virus 3 Type 3Type 310Parainfluenza virus 4 Type 4Type 4 (subtype A)5000Respiratory syncytial virusType A2*Bordetella pertussis*A6394000 CFU/mL*Chlamydophila pneumoniae*TW1833000 DNA copies/mL*Mycoplasma pneumoniae*M129 (Type 1)30[^1]

2.3. Reverse transcription PCR (RT-PCR) analysis {#sec0025}
------------------------------------------------

The total nucleic acid was automatically isolated from the nasopharyngeal swabs using the MagMax Viral/Pathogen Nucleic Acid Isolation Kit (Thermo Fisher Scientific, Waltham, MA, USA) on KingFisher Duo Prime (Thermo Fisher Scientific) as previously described \[[@bib0030],[@bib0035]\]. To detect SARS-CoV-2, we performed RT-PCR as previously described \[[@bib0035],[@bib0040]\]. The RT-PCR assays were conducted on a StepOnePlus Real-Time PCR System with the following cycling conditions: 50 °C for 5 min for reverse transcription, 95 °C for 20 s, and 45 cycles of 95 °C for 3 s and 60 °C for 30 s. The threshold cycle (Ct) value was assigned to each PCR reaction, and the amplification curve was visually assessed.

3. Results {#sec0030}
==========

Of 191 patients, 32 (17 %) were infected at least one causative virus, including human rhinovirus/enterovirus (n = 11), human metapneumovirus (n = 7), coronavirus 229E (n = 4), coronavirus OC43 (n = 3), adenovirus (n = 2), respiratory syncytial virus (n = 2) and coronavirus NL63 (n = 1) ([Table 2](#tbl0010){ref-type="table"} ). Two patients were simultaneously infected with two viruses each, one with adenovirus and human rhinovirus/enterovirus and one with adenovirus and human metapneumovirus ([Table 2](#tbl0010){ref-type="table"}). However, no influenza A, A/H1, A/H3, A/H1-2009 or B viruses were detected. Thus, influenza viruses either have a very low prevalence in our district or were prevented by the intensive measures taken against coronaviruses.Table 2Numbers of patients infected with SARS-CoV-2 and other respiratory infection viruses (n = 40).Table 2Virusesn Human rhinovirus/enterovirus11 SARS-CoV-2[\*](#tblfn0005){ref-type="table-fn"}8 Human metapneumovirus7 Coronavirus 229E4 Coronavirus OC433 Adenovirus2 Respiratory syncytial virus2 Coronavirus NL631 Adenovirus and human rhinovirus/enterovirus1 Adenovirus and human metapneumovirus1 Coronavirus HKU10 Influenza A0 Influenza A/H10 Influenza A/H1-20090 Influenza A/H30 Influenza B0 Parainfluenza 10 Parainfluenza 20 Parainfluenza 30 Parainfluenza 40  **Bacteria** *Bordetella pertussis*0 *Chlamydophila pneumoniae*0 *Mycoplasma pneumoniae*0**Total**40[^2][^3]

RT-PCR performed on samples from the same cohort of 191 patients detected that 8 were infected with SARS-CoV-2. The FilmArray Respiratory Panel showed that these 8 patients were uninfected with any other causative virus ([Fig. 1](#fig0005){ref-type="fig"} ). Thus, the SARS-CoV-2 infection prevalence was 4 %, while the influenza viral prevalence was 0 % in this cohort ([Fig. 1](#fig0005){ref-type="fig"}). This comparative analysis suggests that SARS-CoV-2 was much more infectious than the influenza viruses were under the same conditions in the same region.Fig. 1Viral infection status among 191 patients.Flowchart showing the number of patients infected with causative viruses. A FilmArray Respiratory Panel detected 32 positive and 159 negative patients. RT-PCR analysis detected SARS-CoV-2 in 8 patients.Fig. 1

The respiratory panel detected that 17 % of the cohort (32/191 patients) were infected with causative viruses. Seven viral species were detected, none of which were influenza viruses. At the start of the coronavirus epidemic, the infectivity of SARS-CoV-2 was unknown compared to that of influenza viruses. Our data implies that influenza viral spread would be suppressed under the preventive measure.

4. Discussion {#sec0035}
=============

This study evaluated the differences in infectivity between SARS-CoV-2 and influenza viruses. Infection prevention measures, such as handwashing and mask wearing, led to fewer influenza infections \[[@bib0045]\]. Mask wearing is a common practice among Japanese in the winter. After Japanese government announced on the citizen to take preventive measures, "behavioural changes" (i.e. avoid crowded places, wearing a mask, handwashing with soap and hand sanitizers) were as clearly observed at the end of March \[[@bib0050]\]. Sakamoto *et.al.* analyzed epidemiological data from 2014 to 2020 and showed that the number of seasonal influenza cases was lower in 2020 than in previous years in Japan \[[@bib0020]\]. These observations along with the current results suggest different infectious activity levels between seasonal influenza viruses and SARS-CoV2.

We revealed the infection rate of respiratory viruses as well as SARS-CoV-2 ([Table 2](#tbl0010){ref-type="table"}). Recent study showed surgical mask is important to prevent viral shedding \[[@bib0045]\]. In particular, detection rate of common coronavirus and influenza virus decreased in droplet and aerosol after waring mask, but less effective for rhinovirus \[[@bib0045]\]. Concordant with these results, our data showed highest infection rate is caused by the rhinovirus / enterovirus. Common coronavirus such as 229E, OC43 and NL63 were detected in a few patients compared to SARS-CoV-2. Although it still unknown to what extent face mask has the same effects in SARS-CoV-2 to common coronavirus, it could be important for preventing airborne transmission \[[@bib0055]\].

Although this was a prospective study, there were limitations. First, this study was conducted by a single-center in our district. National registry indicated a marked reduction in influenza viral infections at the end rather than at the beginning of winter \[[@bib0020]\], which coincided with our study. Second, it needs a comparator group. A retrospective and/or prospective study with data before and after preventive measure against would answer the difference of infectivity among viruses. Third, the influenza vaccination status was not investigated. The less infection rate of influenza virus would be explained by vaccination. Instead, we examined the statistical surveys of vaccination rates for all Japanese citizens published by the government. Overall trend shows the vaccination rate from 2007 to 2017 is almost 50 % (range: 48.2 %--55.9 %). Although the latest data are not yet available, it is likely that the vaccination rate would not change significantly in 2020. In this context, further studies should verify whether preventive social measures reduced the infection prevalence of influenza viral transmission.

This study showed that taking stringent measures may prevent influenza viruses, which have more strongly affected human life for a longer time.
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[^1]: TCID~50~, Tissue Culture Infectious Dose 50; CFU, colony forming unit

[^2]: SARS-CoV-2, severe acute respiratory coronavirus 2.

[^3]: SARS-CoV-2 was detected by RT-PCR.
